Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

682

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Influenza Immunization
Interventions
BIOLOGICAL

Quadrivalent Influenza mRNA Vaccine MRT5413

"Pharmaceutical Form: Liquid frozen solution in a vial~Route of Administration: Intramuscular injection"

BIOLOGICAL

Quadrivalent Recombinant Influenza Vaccine

"Pharmaceutical Form: Liquid frozen solution in a vial~Route of Administration: Intramuscular injection"

BIOLOGICAL

Quadrivalent Influenza Standard Dose Vaccine

"Pharmaceutical Form: Liquid suspension for injection in pre-filled syringe~Route of Administration: Intramuscular injection"

BIOLOGICAL

Quadrivalent Influenza High-Dose Vaccine

"Pharmaceutical Form: Liquid suspension for injection in pre-filled syringe~Route of Administration: Intramuscular injection"

Trial Locations (35)

2010

Investigational Site Number : 0360004, Darlinghurst

2035

Investigational Site Number : 0360003, Maroubra

2259

Investigational Site Number : 0360005, Kanwal

3051

Investigational Site Number : 0360002, North Melbourne

4506

Investigational Site Number : 0360001, Morayfield

14609

Rochester Clinical Research. Inc. Site Number : 8400027, Rochester

29405

Coastal Carolina Research Center Site Number : 8400042, North Charleston

31406

Meridian Clinical Research Site Number : 8400022, Savannah

32132

Velocity New Smyrna Beach Site Number : 8400063, Edgewater

32607

SIMEDHealth, LLC Site Number : 8400014, Gainesville

32789

Florida Pulmonary Research Center Site Number : 8400036, Winter Park

33012

Indago Research and Health Center Site Number : 8400044, Hialeah

33024

Cenexel Research Centers of America Site Number : 8400011, Hollywood

33173

Florida International Research Center Site Number : 8400045, Miami

Suncoast Research Associates, LLC Site Number : 8400060, Miami

37421

ClinSearch Site Number : 8400013, Chattanooga

44122

Velocity Clinical Research Site Number : 8400001, Cleveland

46260

Brengle Family Medicine Site Number : 8400039, Indianapolis

60305

DM Clinical Research - Chicago Site Number : 8400025, River Forest

68134

Velocity Clinical Research Site Number : 8400008, Omaha

68510

Velocity Clinical Research Lincoln Site Number : 8400049, Lincoln

68701

Meridian Clinical Research Site Number : 8400017, Norfolk

77081

DM Clinical Research- Bellaire Site Number : 8400026, Houston

78229

Clinical Trials of Texas, Inc. - PPDS Site Number : 8400016, San Antonio

78704

Elligo Health Research, Inc. Site Number : 8400002, Austin

83642

Velocity Clinical Research Site Number : 8400024, Meridian

90247

Velocity Gardena Site Number : 8400062, Gardena

90806

Long Beach Clinical Trials Site Number : 8400052, Long Beach

91606

Velocity Clinical Research, North Hollywood Site Number : 8400051, North Hollywood

91911

Velocity Clinical Research-Chula Vista Site Number : 8400061, Chula Vista

92123-1881

California Research Foundation Site Number : 8400006, San Diego

32720-0834

Accel Clinical Research-Deland Clinical Research Unit Site Number : 8400032, DeLand

02818

Velocity Clinical Research - Providence Site Number : 8400019, East Greenwich

00694

Investigational Site Number : 6300001, Barrio Sabana

00909

Investigational Site Number : 6300002, San Juan

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY